BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol 2014; 20(20): 6031-6043 [PMID: 24876726 DOI: 10.3748/wjg.v20.i20.6031]
URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6031.htm
Number Citing Articles
1
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Faezeh Niazi Shahraki, Nadia Zandi, Benyamin Pazoki, Mohammad Hosein Farzaei, Mehdi Ghasemi, Mohammad Abdollahi, Amir Hossein Abdolghaffari. Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal DisordersCurrent Pharmaceutical Biotechnology 2024; 25(13): 1632 doi: 10.2174/0113892010261502231102040149
2
Krzysztof Drygalski, Mateusz Maciejczyk, Urszula Miksza, Andrzej Ustymowicz, Joanna Godzień, Angelika Buczyńska, Andrzej Chomentowski, Iga Walczak, Karolina Pietrowska, Julia Siemińska, Cezary Pawlukianiec, Przemysław Czajkowski, Joanna Fiedorczuk, Monika Moroz, Beata Modzelewska, Anna Zalewska, Barbara Kutryb-Zając, Tomasz Kleszczewski, Michał Ciborowski, Hady Razak Hady, Marc Foretz, Edyta Adamska-Patruno. New Application of an Old Drug: Anti-Diabetic Properties of PhloroglucinolInternational Journal of Molecular Sciences 2024; 25(19): 10291 doi: 10.3390/ijms251910291
3
Esther Colomier, Joost Algera, Chloé Melchior. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With DiarrheaFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.629026
4
Syed Kashif, Rema Razdan, Ramanaiah Illuri. Potential of phloroglucinol to improve erectile dysfunction associated with streptozotocin-induced diabetes in ratsJournal of Integrative Medicine 2019; 17(4): 282 doi: 10.1016/j.joim.2019.04.002
5
Xiao-Lin Wang, Jian-Ning Zhou, Li Ren, Xiao-Li Pan, Hong-Yu Ren, Jun Liu. Improvement of Quality of Nonanesthetic Colonoscopy by Preoperative Administration of Pinaverium BromideChinese Medical Journal 2017; 130(6): 631 doi: 10.4103/0366-6999.201597
6
Ahmed H. Naggar, Ahmed Kotb, Ahmed A. Gahlan, Mahmoud H. Mahross, Abd El-Aziz Y. El-Sayed, Adel A. Abdelwahab. Graphite Studded with Facile-Synthesized Cu2O Nanoparticle-Based Cubes as a Novel Electrochemical Sensor for Highly Sensitive Voltametric Determination of Mebeverine HydrochlorideChemosensors 2021; 9(2): 35 doi: 10.3390/chemosensors9020035
7
Valeria Atenea Costa, Alan Felipe Ovalle Hernández. Rol de los antiespasmódicos en el manejo del síndrome de intestino irritableRevista Colombiana de Gastroenterología 2019; 34(3): 269 doi: 10.22516/25007440.309
8
Marilisa Straface, Raj Makwana, Alexandra Palmer, Laura Rombolà, Joanne Aleong, Luigi Morrone, Gareth Sanger. Inhibition of Neuromuscular Contractions of Human and Rat Colon by Bergamot Essential Oil and Linalool: Evidence to Support a Therapeutic ActionNutrients 2020; 12(5): 1381 doi: 10.3390/nu12051381
9
Lei Zhang, Ruiyun Wang, Tao Bai, Xuelian Xiang, Wei Qian, Jun Song, Xiaohua Hou. EphrinB2/ephB2‐mediated myenteric synaptic plasticity: mechanisms underlying the persistent muscle hypercontractility and pain in postinfectious IBSThe FASEB Journal 2019; 33(12): 13644 doi: 10.1096/fj.201901192R
10
Magnus Simrén, Jan Tack. New treatments and therapeutic targets for IBS and other functional bowel disordersNature Reviews Gastroenterology & Hepatology 2018; 15(10): 589 doi: 10.1038/s41575-018-0034-5
11
Simona Codruta Heghes, Oliviu Vostinaru, Lucia Maria Rus, Cristina Mogosan, Cristina Adela Iuga, Lorena Filip. Antispasmodic Effect of Essential Oils and Their Constituents: A ReviewMolecules 2019; 24(9): 1675 doi: 10.3390/molecules24091675
12
Biswanath Dinda. Pharmacology and Applications of Naturally Occurring Iridoids2019; : 145 doi: 10.1007/978-3-030-05575-2_5
13
Biplab Rajbanshi, Koyeli Das, Debadrita Roy, Subhadeep Saha, Mahendra Nath Roy. Exploring 2:1 inclusion complexes of cyclodextrins and antispasmodics, Alverine citrate for enhancing bioavailability and sustained dischargementJournal of Molecular Liquids 2023; 370: 121036 doi: 10.1016/j.molliq.2022.121036
14
Beatrix Pfanzagl, Victor F. Zevallos, Detlef Schuppan, Roswitha Pfragner, Erika Jensen-Jarolim. Histamine causes influx via T-type voltage-gated calcium channels in an enterochromaffin tumor cell line: potential therapeutic target in adverse food reactionsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(2): G291 doi: 10.1152/ajpgi.00261.2018
15
Orhan Atay, Jennie David, Ami Mehta. A Hypothetical Case Example Illustrating the Importance of a Multidisciplinary Approach to Treating Chronic/Functional Abdominal Pain in Pediatric PatientsPediatric Clinics of North America 2022; 69(5): 917 doi: 10.1016/j.pcl.2022.06.005
16
Abdalsalam Kmail. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compoundsOpen Life Sciences 2024; 19(1) doi: 10.1515/biol-2022-0857
17
Lauren Stemboroski, Ron Schey. Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel SyndromeGastroenterology Clinics of North America 2020; 49(3): 607 doi: 10.1016/j.gtc.2020.05.001
18
Yahong Chen, Xiaohong Wang, Haifeng Zhai, Yanling Zhang, Jianmei Huang. Identification of Potential Human Ryanodine Receptor 1 Agonists and Molecular Mechanisms of Natural Small-Molecule Phenols as AnxiolyticsACS Omega 2021; 6(44): 29940 doi: 10.1021/acsomega.1c04468
19
Daisy S. Precilla, Shreyas S. Kuduvalli, Mugilarasi Purushothaman , Parthiban Marimuthu, Arumugam Ramachandran Muralidharan, Thirugnanasambandham Sivasubramanian Anitha. Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma MultiformeCurrent Molecular Pharmacology 2022; 15(2): 338 doi: 10.2174/1874467214666210420115431
20
Giovanni Di Nardo, Giovanni Barbara, Osvaldo Borrelli, Cesare Cremon, Valentina Giorgio, Luigi Greco, Michele La Pietra, Giovanni Marasco, Licia Pensabene, Marisa Piccirillo, Claudio Romano, Silvia Salvatore, Michele Saviano, Vincenzo Stanghellini, Caterina Strisciuglio, Renato Tambucci, Rossella Turco, Letizia Zenzeri, Annamaria Staiano. Italian guidelines for the management of irritable bowel syndrome in children and adolescentsItalian Journal of Pediatrics 2024; 50(1) doi: 10.1186/s13052-024-01607-y
21
Sagar Suman Panda, Venkata Varaha Ravi Kumar Bera, Padmalaya Sahoo, Biswajit Sahu. Quantitative estimation of mebeverine hydrochloride in sustained-release dosage form using an analytical lifecycle management oriented stability-indicating LC methodJournal of Liquid Chromatography & Related Technologies 2018; 41(10): 637 doi: 10.1080/10826076.2018.1500376
22
Susan Lucak, Lin Chang, Albena Halpert, Lucinda A. Harris. Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practiceTherapeutic Advances in Gastroenterology 2017; 10(2): 253 doi: 10.1177/1756283X16663396
23
Jing Wu, Qinwei Fu, Shasha Yang, Hui Wang, Yaofeng Li, Tarique Hussain. Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea‐Predominant Irritable Bowel Syndrome and Constipation‐Predominant Irritable Bowel Syndrome: A Systematic Review and Meta‐AnalysisEvidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/5812320
24
Magnus Simrén, Hans Törnblom, Olafur S Palsson, William E Whitehead. Management of the multiple symptoms of irritable bowel syndromeThe Lancet Gastroenterology & Hepatology 2017; 2(2): 112 doi: 10.1016/S2468-1253(16)30116-9
25
Paul Moayyedi, Fermín Mearin, Fernando Azpiroz, Viola Andresen, Giovanni Barbara, Maura Corsetti, Anton Emmanuel, A Pali S Hungin, Peter Layer, Vincenzo Stanghellini, Peter Whorwell, Frank Zerbib, Jan Tack. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practiceUnited European Gastroenterology Journal 2017; 5(6): 773 doi: 10.1177/2050640617731968
26
Huaiyu Li, Yun Chen, Ziyi Hu, Ying Yi, Jing Ye, Yuliang Zhou, Zhiying Yu, Haiyi Tang. Comparison of acupuncture and pinaverium bromide in the treatment of irritable bowel syndromeMedicine 2021; 100(16): e25604 doi: 10.1097/MD.0000000000025604
27
V. N. Drozdov, K. I. Arefev, S. Yu. Serebrova, I. A. Komissarenko, E. V. Shikh, A. K. Starodubtsev. Role of antispasmodics in the treatment of irritable bowel syndromeMeditsinskiy sovet = Medical Council 2021; (5): 155 doi: 10.21518/2079-701X-2021-5-155-164
28
Muqeet Wahid, Fatima Saqib, Muhammad Qamar, Zyta M. Ziora. Antispasmodic activity of the ethanol extract of Citrullus lanatus seeds: Justifying ethnomedicinal use in Pakistan to treat asthma and diarrheaJournal of Ethnopharmacology 2022; 295: 115314 doi: 10.1016/j.jep.2022.115314
29
Andrea Brusaferro, Edoardo Farinelli, Letizia Zenzeri, Rita Cozzali, Susanna Esposito. The Management of Paediatric Functional Abdominal Pain Disorders: Latest EvidencePediatric Drugs 2018; 20(3): 235 doi: 10.1007/s40272-018-0287-z
30
Di Qin, Qing-Feng Tao, Shi-Le Huang, Min Chen, Hui Zheng. Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.757969
31
Konstantinos E. Keramaris, Konstantinos Konstantopoulos, Lukas H. Margaritis, Athanassios D. Velentzas, Issidora S. Papassideri, Dimitrios J. Stravopodis. Exploitation of Drosophila Choriogenesis Process as a Model Cellular System for Assessment of Compound Toxicity: the Phloroglucinol ParadigmScientific Reports 2020; 10(1) doi: 10.1038/s41598-019-57113-3
32
Mustafa Arısoy, Mehtap Saydam, Yasemin Ekin Dolaksız, Çağrı Talay, Onursal Sağlam, Gökçe Demiray, Emel Doğan Kurtoğlu. A Study to Compare Bioequivalence Approach Between FDA and EMA in a Highly Variable Drug: Pinaverium Bromide Film TabletsJournal of Pharmaceutical Sciences 2022; 111(11): 3149 doi: 10.1016/j.xphs.2022.08.010
33
Caroline Valibouze, Caroline Dubuquoy, Philippe Chavatte, Michaël Genin, Veronique Maquet, Salvatore Modica, Pierre Desreumaux, Christel Rousseaux. Chitin-glucan improves important pathophysiological features of irritable bowel syndromeWorld Journal of Gastroenterology 2024; 30(16): 2258-2271 doi: 10.3748/wjg.v30.i16.2258
34
Edward Thomas Andrews, R Mark Beattie, Mark P Tighe. Functional abdominal pain: what clinicians need to knowArchives of Disease in Childhood 2020; 105(10): 938 doi: 10.1136/archdischild-2020-318825
35
O. V. Krapivnaya, S. A. Alekseenko. Comparative evaluation of efficacy of Pinaverium monotherapy and combination therapy of Pinaverium with itopride hydrochloride in patients with cross irritable bowel syndrome with constipation and postpradial distress syndromeMedical alphabet 2019; 3(20): 54 doi: 10.33667/2078-5631-2019-2-20(395)-54-57
36
Dhiraj M. Rathod, Keyur R. Patel, Hiren N. Mistri, Arvind G. Jangid, Pranav S. Shrivastav, Mallika Sanyal. An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆Journal of Pharmaceutical Analysis 2017; 7(2): 95 doi: 10.1016/j.jpha.2016.11.003
37
Khushi Anand, Mahalaqua Nazli Khatib. Causative Factors, Clinical Manifestations, and Therapeutic Strategies for Irritable Bowel SyndromeCureus 2024;  doi: 10.7759/cureus.58728
38
Mihaela Stoyanova, Miglena Milusheva, Vera Gledacheva, Iliyana Stefanova, Mina Todorova, Nikoleta Kircheva, Silvia Angelova, Mina Pencheva, Kirila Stojnova, Slava Tsoneva, Stoyanka Nikolova. Spasmolytic Activity and Anti-Inflammatory Effect of Novel Mebeverine DerivativesBiomedicines 2024; 12(10): 2321 doi: 10.3390/biomedicines12102321
39
Clara Blanchard, Denis Pouchain, Paul Vanderkam, Marie-Christine Perault-Pochat, Rémy Boussageon, Hélène Vaillant-Roussel. Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placeboEuropean Journal of Clinical Pharmacology 2018; 74(5): 541 doi: 10.1007/s00228-018-2416-6
40
Saeed Mehrzadi, Mohammad Sheibani, Fereshteh Koosha, Nazila Alinaghian, Mohammad Hossein Pourhanifeh, Seid Amir Pasha Tabaeian, Russel J. Reiter, Azam Hosseinzadeh. Protective and therapeutic potential of melatonin against intestinal diseases: updated review of current data based on molecular mechanismsExpert Review of Gastroenterology & Hepatology 2023; 17(10): 1011 doi: 10.1080/17474124.2023.2267439
41
Di Qin, Ling Yue, Bin Xue, Min Chen, Tai-Chun Tang, Hui Zheng. Pharmacological treatments for patients with irritable bowel syndromeMedicine 2019; 98(32): e15920 doi: 10.1097/MD.0000000000015920
42
Serhat Bor, Philippe Lehert, Adriana Chalbaud, Jan Tack. Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysisTherapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211033740
43
Wenhui Yang, Hua Guo, Jinbo Niu, Junya Liu, Ran Su, Yingde Bai, Shuang Zhang, Qian Liu, Nan Sun. Phloroglucinol inhibits oxytocin-induced contraction in rat gastric circular muscle and uterine smooth muscleJournal of Obstetrics and Gynaecology 2023; 43(1) doi: 10.1080/01443615.2022.2130208
44
Giovanni Barbara, Cesare Cremon, Massimo Bellini, Maura Corsetti, Giovanni Di Nardo, Francesca Falangone, Lorenzo Fuccio, Francesca Galeazzi, Paola Iovino, Giovanni Sarnelli, Edoardo Vincenzo Savarino, Vincenzo Stanghellini, Annamaria Staiano, Cristina Stasi, Cesare Tosetti, Rossella Turco, Enzo Ubaldi, Rocco Maurizio Zagari, Letizia Zenzeri, Giovanni Marasco. Italian guidelines for the management of irritable bowel syndromeDigestive and Liver Disease 2023; 55(2): 187 doi: 10.1016/j.dld.2022.11.015
45
Jia-Jie Zhu, Shan Liu, Xiao-Lan Su, Zi-Song Wang, Yu Guo, Yi-Jie Li, Yang Yang, Li-Wei Hou, Qing-Guo Wang, Ru-Han Wei, Jian-Qin Yang, Wei Wei, Jiande D. Z. Chen. Efficacy of Chinese Herbal Medicine for Diarrhea‐Predominant Irritable Bowel Syndrome: A Meta‐Analysis of Randomized, Double‐Blind, Placebo‐Controlled TrialsEvidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4071260
46
Niranga Manjuri Devanarayana, Shaman Rajindrajith. Irritable bowel syndrome in children: Current knowledge, challenges and opportunitiesWorld Journal of Gastroenterology 2018; 24(21): 2211-2235 doi: 10.3748/wjg.v24.i21.2211
47
Alshimaa M.M. Farag, Hussam M.M. Ibrahim. Does Intravenous Ondansetron Affect the Intestinal Motility Pattern in Healthy Donkeys (Equus asinus)?Journal of Equine Veterinary Science 2021; 101: 103427 doi: 10.1016/j.jevs.2021.103427
48
Orla Craig. New therapies in Irritable Bowel SyndromeCurrent Opinion in Gastroenterology 2018; 34(1): 50 doi: 10.1097/MOG.0000000000000411
49
Shuai Gao, Xia Yao, Jiaofeng Chen, Gaoxingyu Huang, Xiao Fan, Lingfeng Xue, Zhangqiang Li, Tong Wu, Yupeng Zheng, Jian Huang, Xueqin Jin, Yan Wang, Zhifei Wang, Yong Yu, Lei Liu, Xiaojing Pan, Chen Song, Nieng Yan. Structural basis for human Cav1.2 inhibition by multiple drugs and the neurotoxin calciseptineCell 2023; 186(24): 5363 doi: 10.1016/j.cell.2023.10.007
50
Teodora Surdea Blaga, Dan L. Dumitrascu, Andrei V. Pop, Simona Grad. The Complex Interplay Between Gut-Brain, Gut-Liver, and Liver-Brain Axes2021; : 17 doi: 10.1016/B978-0-12-821927-0.00008-5
51
Oleg N. Minushkin, Olga V. Khlynova, Stanislav I. Sitkin, Emilia P. Yakovenko, Yuri A. Kravchuk, Pavel V. Seliverstov, Elena A. Belousova. The potential for improving the efficacy of treatment for irritable bowel syndrome with a multi-target drug alverine citrate plus simethicone: The Expert Panel StatementAlmanac of Clinical Medicine 2024; 52(4): 241 doi: 10.18786/2072-0505-2024-52-023
52
Jaroslaw Daniluk, Ewa Malecka-Wojciesko, Barbara Skrzydlo-Radomanska, Grazyna Rydzewska. The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic ReviewJournal of Clinical Medicine 2022; 11(4): 1044 doi: 10.3390/jcm11041044
53
Kyung Ho Song, Hye-Kyung Jung, Hyun Jin Kim, Hoon Sup Koo, Yong Hwan Kwon, Hyun Duk Shin, Hyun Chul Lim, Jeong Eun Shin, Sung Eun Kim, Dae Hyeon Cho, Jeong Hwan Kim, Hyun Jung Kim. Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised EditionJournal of Neurogastroenterology and Motility 2018; 24(2): 197 doi: 10.5056/jnm17145
54
Shaman Rajindrajith, Judith Zeevenhooven, Niranga Manjuri Devanarayana, Bonaventure Jayasiri Crispus Perera, Marc A. Benninga. Functional abdominal pain disorders in childrenExpert Review of Gastroenterology & Hepatology 2018; 12(4): 369 doi: 10.1080/17474124.2018.1438188
55
Yun-zhou Shi, Qing-feng Tao, Di Qin, Min Chen, Shu-guang Yu, Hui Zheng. Acupuncture vs. antispasmodics in the treatment of irritable bowel syndrome: An adjusted indirect treatment comparison meta-analysisFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1001978
56
Liang Zheng, Weimin Lu, Qi Xiao, Yaoliang Lai, Heng Fan, Yuling Sun, Dawei Huang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Xingxing Liu, Lijuan Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Huisuo Huang, Yongqiang Yang, Zongxiang Tang, Jun Xiao. Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trialScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92990-7
57
K. N. Khalaidzheva, V. N. Drozdov, E. V. Shikh, S. Yu. Serebrova. The place of antispasmodic drugs in modern therapy of irritable bowel syndromeMeditsinskiy sovet = Medical Council 2023; (8): 189 doi: 10.21518/ms2023-127
58
Ming Xia. Visceral Pain2024; : 305 doi: 10.1007/978-981-99-9167-9_15
59
Dezhen Chen, Wangting Zhou, Yujing Wei, Chenghan Zhuang, Yazheng He, Xiaoli Li, Kaibo Li, Zhaoxia Zhang, Guoqing Zhang. Crystal structure and Hirshfeld surface analysis of pinaverium bromide dihydratePowder Diffraction 2024; : 1 doi: 10.1017/S0885715624000423
60
Ramesh R. Rai, Sandeep Nijhawan. Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndromeSaudi Journal of Gastroenterology 2021; 27(3): 136 doi: 10.4103/sjg.SJG_266_20
61
J. Scanzi, A. Accarie, E. Muller, B. Pereira, Y. Aissouni, M. Goutte, J. Joubert‐Zakeyh, E. Picard, L. Boudieu, C. Mallet, A. Gelot, D. Ardid, F. A. Carvalho, M. Dapoigny. Colonic overexpression of the T‐type calcium channel Cav3.2 in a mouse model of visceral hypersensitivity and in irritable bowel syndrome patientsNeurogastroenterology & Motility 2016; 28(11): 1632 doi: 10.1111/nmo.12860
62
William E. Bennett. Quantitative Risk–Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel DiseaseDrug Safety 2016; 39(4): 295 doi: 10.1007/s40264-015-0349-x
63
Gamal A. E. Mostafa, Maha F. El-Tohamy, Haitham Alrabiah. Prospective of Agro-Waste Husks for Biogenic Synthesis of Polymeric-Based CeO2/NiO Nanocomposite Sensor for Determination of Mebeverine HydrochlorideMolecules 2023; 28(5): 2095 doi: 10.3390/molecules28052095
64
Simona Rizea-Savu, Simona Nicoleta Duna, Roxana Colette Sandulovici. Single Dose Study Assessing the Pharmacokinetic and Metabolic Profile of Alverine Citrate in Healthy VolunteersFrontiers in Pharmacology 2021; 11 doi: 10.3389/fphar.2020.620451
65
V. T. Ivashkin, Y. A. Shelygin, E. K. Baranskaya, S. I. Achkasov, S. S. Belous, E. A. Belousova, A. G. Beniashviili, S. V. Vasiliev, E. G. Grigoriev, N. V. Kostenko, A. I. Moskalev, V. N. Kashnikov, I. D. Loranskaya, O. S. Lyashenko, E. A. Poluektova, V. G. Rumyantsev, V. M. Timerbulatov, E. Y. Chashkova, M. V. Shapina, A. A. Sheptulin, O. S. Shifrin, O. Y. Zolnikova, A. Y. Baranovsky, N. V. Korochanskaya, S. N. Mammaev, O. P. Alekseeva, I. B. Khlynov, V. V. Tsukanov, S. A. Alekseenko. Irritable bowel syndromeKoloproktologia 2022; 21(1): 10 doi: 10.33878/2073-7556-2022-21-1-10-25
66
Dmitry I. Trukhan, Viktoriia V. Goloshubina. Irritable bowel syndrome: current aspects of etiology, pathogenesis, clinic and treatment: A reviewConsilium Medicum 2022; 24(5): 297 doi: 10.26442/20751753.2022.5.201861
67
Kwang Jae Lee. Pharmacologic Agents for Chronic DiarrheaIntestinal Research 2015; 13(4): 306 doi: 10.5217/ir.2015.13.4.306
68
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. Consenso mexicano sobre el síndrome de intestino irritableRevista de Gastroenterología de México 2016; 81(3): 149 doi: 10.1016/j.rgmx.2016.01.004
69
Amber Hanif Palla, Gereziher Gebremedhin Sibhat, Aman Karim, Najeeb Ur Rehman, Mebrahtom Gebrelibanos Hiben. <p>Multiple Pathway–Mediated Gut-Modulatory Effects of <em>Maerua subcordata</em> (Gilg) DeWolf</p>Journal of Experimental Pharmacology 2020; : 203 doi: 10.2147/JEP.S254818
70
Emidio Scarpellini, Lucrezia Laterza, Gianluca Ianiro, Jan Tack, Ludovico Abenavoli, Antonio Gasbarrini. Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndromeExpert Opinion on Pharmacotherapy 2016; 17(10): 1395 doi: 10.1080/14656566.2016.1182982
71
Krzysztof Drygalski, Katarzyna Siewko, Andrzej Chomentowski, Cezary Odrzygóźdź, Anna Zalewska, Adam Krętowski, Mateusz Maciejczyk, Ayman Mahmoud. Phloroglucinol Strengthens the Antioxidant Barrier and Reduces Oxidative/Nitrosative Stress in Nonalcoholic Fatty Liver Disease (NAFLD)Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/8872702
72
Aiya Aboubakr, Michelle S. Cohen. Functional Bowel DiseaseClinics in Geriatric Medicine 2021; 37(1): 119 doi: 10.1016/j.cger.2020.08.009
73
Yucui Zhao, Jiaguo Zhan, Congying Sun, Shixiao Zhu, Yue Zhai, Yongna Dai, Xiaoying Wang, Xiumei Gao. Sishen Wan enhances intestinal barrier function via regulating endoplasmic reticulum stress to improve mice with diarrheal irritable bowel syndromePhytomedicine 2024; 129: 155541 doi: 10.1016/j.phymed.2024.155541
74
Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy M. A. E. Jonkers, Marieke J. Pierik, Zlatan Mujagic. Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remissionAlimentary Pharmacology & Therapeutics 2024; 59(12): 1470 doi: 10.1111/apt.17988
75
Sheyda Ranjbar, Seyed Afshin Seyednejad, Shekoufeh Nikfar, Roja Rahimi, Mohammad Abdollahi. How can we develop better antispasmodics for irritable bowel syndrome?Expert Opinion on Drug Discovery 2019; 14(6): 549 doi: 10.1080/17460441.2019.1593369
76
V. T. Ivashkin, I. V. Maev, Yu. A. Shelygin, E. K. Baranskaya, S. S. Belous, E. A. Belousova, A. G. Beniashvili, S. V. Vasilyev, A. V. Veselov, E. G. Grigoryev, N. V. Kostenko, V. N. Kashnikov, V. F. Kulikovskiy, I. D. Loranskaya, O. S. Lyashenko, E. A. Poluektova, V. G. Rumyantsev, V. M. Timerbulatov, O. Yu. Fomenko, D. A. Khubezov, E. Yu. Chashkova, G. I. Chibisov, M. V. Shapina, A. A. Sheptulin, O. S. Shifrin, A. S. Trukhmanov, O. P. Alekseeva, S. A. Alekseenko, A. Yu. Baranovsky, O. Yu. Zolnikova, N. V. Korochanskaya, S. N. Mammayev, I. B. Khlynov, V. V. Tsukanov. Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of RussiaRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5): 74 doi: 10.22416/1382-4376-2021-31-5-74-95
77
Robyn Rexwinkel, Arine M. Vlieger, Miguel Saps, Merit M. Tabbers, Marc A. Benninga. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specifiedEuropean Journal of Pediatrics 2022; 181(7): 2603 doi: 10.1007/s00431-022-04459-y
78
Qiang-Song Wang, Yi-Lun Wang, Wen-Yan Zhang, Kuang-Dai Li, Xiong-Fei Luo, Yuan-Lu Cui. Puerarin from Pueraria lobata alleviates the symptoms of irritable bowel syndrome-diarrheaFood & Function 2021; 12(5): 2211 doi: 10.1039/D0FO02848G
79
Conor O’Croinin, Andres Garcia Guerra, Michael R. Doschak, Raimar Löbenberg, Neal M. Davies. Therapeutic Potential and Predictive Pharmaceutical Modeling of Stilbenes in Cannabis sativaPharmaceutics 2023; 15(7): 1941 doi: 10.3390/pharmaceutics15071941
80
O.Yu. Belousova. Irritable bowel syndrome in childhood: treatment in accordance with international guidelinesCHILD`S HEALTH 2024; 19(2): 92 doi: 10.22141/2224-0551.19.2.2024.1681
81
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. The Mexican consensus on irritable bowel syndromeRevista de Gastroenterología de México (English Edition) 2016; 81(3): 149 doi: 10.1016/j.rgmxen.2016.01.004
82
Sang Heon Lee, Sam Ryong Jee. Effect of antispasmodic agents for the treatment of irritable bowel syndromeJournal of the Korean Medical Association 2018; 61(7): 428 doi: 10.5124/jkma.2018.61.7.428
83
Hossein Taghadosi, Farhad Tabatabai Ghomsheh, Aydin Farajidavar, Faezeh Khazaee, Fatemeh Hoseinpour. The effect of calcium channels blockade on slow-wave distribution in the electrophysiological model of human gastric wall smooth muscle cellsPhysiology and Pharmacology 2023; 27(3): 319 doi: 10.61186/phypha.27.3.319